Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma

As the first oral multi-target anti-tumor drug proved for the treatment of patients with advanced liver cancer in 2007, sorafenib has changed the landscape of advanced hepatocellular carcinoma (HCC) treatment. However, drug resistance largely hinders its clinical application. Non-coding RNAs (ncRNAs...

全面介绍

书目详细资料
发表在:Frontiers in Oncology
Main Authors: Yongting Lai, Bing Feng, Mubalake Abudoureyimu, Yingru Zhi, Hao Zhou, Ting Wang, Xiaoyuan Chu, Ping Chen, Rui Wang
格式: 文件
语言:英语
出版: Frontiers Media S.A. 2019-11-01
主题:
在线阅读:https://www.frontiersin.org/article/10.3389/fonc.2019.01156/full

相似书籍